Stem cells for clinical use in cardiovascular medicine: Current limitations and future perspectives

Thrombosis and Haemostasis

Volumn 94, Issue 4, 2005, Pages 697-701

  Menasché, Philippe ^a,b,c  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b University of Paris Diderot   (France)

^c INSERM   (France)

Author keywords

Bone marrow; Embryonic stem cells; Heart failure; Myocardial infarction; Skeletal myoblasts; Stem cell

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL REGENERATION; CELL SURVIVAL; CELL TYPE; CLINICAL TRIAL; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEMATOPOIETIC STEM CELL; HUMAN; MEDICAL RESEARCH; MYOBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION;

ANIMALS; CARDIOLOGY; HEART DISEASES; HUMANS; MYOBLASTS, SKELETAL; STEM CELL TRANSPLANTATION;

EID: 27144459609     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-03-0218     Document Type: Article

References (42)

1. Dowell J, Rubart M, Pasumarthi KB et al. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 2003; 58 : 336-50.
2. Reinecke H, Minami E, Poppa V et al. Evidence for fusion between cardiac and skeletal muscle cells. Circulation 2004; 94: 1-5.
3. Rubart M, Soonpaa MH, Nakajima H et al. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest 2004; 114: 775-83.
4. Murtuza B, Suzuki K, Bou-Gharios G et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acd Sci USA 2004; 101: 4216-21.
5. Menasché P, Hagege AA, Vilquin JT et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078-83.
6. Herreros J, Prosper F, Perez A et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003; 24: 2012-20.
7. Siminiak T, Kalawski R, Fiszer D et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 2004;148: 531-7.
8. Dib N, McCarthy P, Dinsmore J et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Interim analysis from the United States experience. Circulation 2002;106(suppl II): II-463 (Abstract).
9. Smits PC, Geuns RJM, Poldermans D et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure. J Am Coll Cardiol 2003; 42: 2063-9.
10. Siminiak T, Fiszer D, Jerykcwska O et al. Percutaneous transvenous transplantation of autologous myoblasts in the treatment of postinfarction myocardial contractility impairment - the POZNAN trial. Eur Heart J 2005; 26: 1188-95.
11. Hagege AA, Carrion C, Menasche P et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003; 361: 91-2.
12. Brasselet C, Carrion C, Morichetti MC et al. Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. Eur Heart J 2005; 26: 1551-6.
13. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-5.
14. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: The scientific foundations of cardiac repair. J Clin Invest 2005; 115: 572-83.
15. Tse HF, Kwong YL, Chan JK et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 36: 47-9.
16. Perin EC, Dohmann HFR, Borojevik R et al. Trans-endocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107: 2294-302.
17. Murry CE, Soonpa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664-8.
18. Alvarez-Dolado M, Pardal R, Garcia-Verdugo J et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocyes. Nature 2003; 425: 968-73.
19. Kinnaird T, Stabile E, Burnett MS et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004; 94: 670-85.
20. Maurel M, Azarnoush K, Sabbah L et al. Patterns of cell death and proliferation after skeletal myoblast transplantation in infarcted rat myocardium. Transplantation (in press).
21. Pedrotty D, Koh J, Davis B et al. Engineering skeletal myoblasts : roles of 3-D culture and electrical stimulation. Am J Physiol Heart Circ Physiol 2005; 288: H1620-6.
22. Chazaud B, Sonnet C, Lafuste P et al. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol 2003; 163: 1133-43.
23. Hofmann M, Wollert KC, Meyer GP et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005; 111: 2198-202.
24. Tambara K, Sakakibara Y, Sakaguchi G et al. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 2003; 108 (Suppl 1) II 259-63.
25. Azarnoush K, Maurel A, Sebbah L et al. Enhancement of the functional benefits of skeletal myoblast transplantation by co-administration of hypoxia-inducible factor 1α. J Thorac Cardiovasc Surg 2005; 130: 173-9.
26. Suzuki K, Murtuza B, Smolenski RT et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 2001; 104 (suppl I):I-207-12.
27. Christman KL, Verdanian AJ, Fang Q et al. Injectable fibrin scaffold improves cell transplant survival reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 2004; 44: 654-60.
28. Himes N, Min JY, Lee R et al. In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn Reson Med 2004; 52: 1214-9.
29. Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 36: 45-6.
30. Yoon YS, Wecker A, Heyd L et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005; 115: 326-38.
31. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-22.
32. Winitsky SO, Gopal TV, Hassanzadeh S et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol 2005; 3: e87.
33. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002; 34: 241-9.
34. Leobon B, Garcin I, Menasche P et al. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 2003; 100: 7808-11.
35. Rastan AJ, Walther T, Kostelka M et al. Morphological, electrophysiological and coupling characteristics of bone marrow-derived mononuclear cells-an in vitro-model. Eur J Cardiothorac Surg 2005; 27: 104-10.
36. Rubart M, Pasumarthi KB, Nakajima H et al. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ Res 2003; 92: 1217-24.
37. +1 cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005; 433: 647-53.
38. Dawn B, Stein AB, Urbanek K et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium and improve cardiac function. Proc Natl Acad Sci USA 2005; 102: 3766-71.
39. Hodgson DM, Behfar A, Zingman LV et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 2004; 287: H471-9.
40. Kehat I, Khimovitch L, Caspi O et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22: 1282-9.
41. Min JY, Yang Y, Sullivan MF et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 2003; 125: 361-9.
42. Pouly J, Hagege AA, Vilquin JT et al. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Circulation 2004; 110: 1626-31.